Are the Mallory bodies and intracellular hyaline bodies in neoplastic and non-neoplastic hepatocytes related?

Journal of Pathology

Volumn 208, Issue 5, 2006, Pages 653-661

  Denk, Helmut ^a   Stumptner, C ^a   Fuchsbichler, A ^a   Muller T ^b   Farr, G H ^c   Muller W ^d   Terracciano, L ^e   Zatloukal, K ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c OCHSNER MEDICAL CENTER   (United States)

^d Hospital Reutte   (Austria)

^e UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Copper toxicosis; Hepatocellular carcinoma; Intracellular hyaline bodies; Keratins; Mallory bodies; p62; Steatohepatitis

Indexed keywords

ADAPTOR PROTEIN; COPPER; HYALIN; KERATIN; PROTEIN P62;

ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; INTOXICATION; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALLORY BODY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

CARCINOMA, HEPATOCELLULAR; COPPER; HEPATOCYTES; HUMANS; HYALIN; INCLUSION BODIES; KERATINS; LIVER DISEASES; LIVER NEOPLASMS; MICROSCOPY, ELECTRON; MICROSCOPY, IMMUNOELECTRON; NEOPLASM PROTEINS; RNA-BINDING PROTEINS;

EID: 33645243056     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.1946     Document Type: Article

References (23)

1. Denk H, Stumptner C, Zatloukal K. Mallory bodies revisited. J Hepatol 2000;32:689-700.
2. Müller T, Langner C, Fuchsbichler A, Heinz-Erian P, Ellemunter H, Schlenck B, et al. Immunohistochemical analysis of Mallory bodies in Wilsonian and non-Wilsonian hepatic copper toxicosis. Hepatology 2004;39:963-969.
3. Stumptner C, Heid H, Fuchsbichler A, Hauser H, Mischinger HJ, Zatloukal K, Denk H. Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma: demonstration of p62 as a major constituent. Am J Pathol 1999;154:1701-1710.
4. Zatloukal K, Stumptner C, Lehner M, Denk H, Baribault H, Eshkind LG, Franke WW. Cytokeratin 8 protects from hepatotoxicity and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies. Am J Pathol 2000;156:1263-1274.
5. Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L, et al. P62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 2002;160:255-263.
6. Stumptner C, Fuchsbichler A, Heid H, Zatloukal K, Denk H. Mallory body - a disease-associated type of sequestosome. Hepatology 2002;35:1053-1062.
7. Sanz L, Sanchez P, Lallena MJ, Diaz-Meco MT, Moscat J. The interaction of p62 with RIP links the atypical PKCs to NF-κB activation. EMBO J 1999;18:3044-3053.
8. Shin J. P62 and the sequestosome, a novel mechanism for protein metabolism. Arch Pharm Res 1998;21:629-633.
9. Geetha T, Wooten MW. Structure and functional properties of the ubiquitin binding protein p62. FEBS Lett 2002;512:19-24.
10. Norkin SA, Campagna-Pinto D. Cytoplasmic hyaline inclusions in hepatoma. Histochemical study. Arch Pathol 1968;86:25-32.
11. Johnston JA, Ward CL, Kopito RR. Aggresomes: a cellular response to misfolded proteins. J Cell Biol 1998;143:1883-1898.
12. Kopito RR. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 2000;10:524-530.
13. Dobson CM. Principle of protein folding, misfolding and aggregation. Sem Cell Dev Biol 2004;15:3-16.
14. Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nature Med 2004;10:S10-S17.
15. Grune T, Jung T, Marken K, Davis KJA. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. Int J Biochem Cell Biol 2004;36:2519-2530.
16. Ludwig J, Farr GH, Freese DK, Sternlieb I. Chronic hepatitis and hepatic failure in a 14 year-old girl. Hepatology 1995;22:1874-1879.
17. Denk H, Krepler R, Lackinger E, Artlieb U, Franke WW. Biochemical and immunocytochemical analysis of the intermediate filament cytoskeleton in human hepatocellular carcinomas and in hepatic neoplastic nodules of mice. Lab Invest 1982;46:584-596.
18. Puls A, Schmidt S, Grawe F, Stahel S. Interaction of protein kinase Cζ with ZIP, a novel protein kinase C-binding protein. Proc Natl Acad Sci USA 1997;94:6191-6196.
19. Kuusisto E, Salminen A, Alafuzoff I. Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. Clin Neurosci Neuropathol 2001;12:2085-2090.
20. Kuusisto E, Suuronen T, Salminen A. Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. Biochem Biophys Res Commun 2001;280:223-228.
21. Ishii T, Itoh K, Sato H, Bannai S. Oxidative stress-inducible proteins in macrophages. Free Radical Res 1999;31:351-355.
22. Ku NO, Omary MB. Keratins turn over by ubiquitination in a phosphorylation-induced fashion. J Cell Biol 2000;149:547-552.
23. Seibenhener ML, Babu JR, Geetha T, Wong HC, Krishna NR, Wooten MW. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol 2004;24:8055-8068.